Nearly 9% of the global population has chronic kidney disease (CKD), defined as either a 40% reduction in the filtering capacity of the kidney or its abnormal leakiness for plasma albumin 1 . Fibrosis is the histological manifest ation of CKD 2 . Strategies that can effectively slow, or even revert, renal fibrosis in patients with CKD could have a marked clinical impact in preventing endstage renal disease, a condition that can only be treated with dialysis or transplantation and is associated with at least a threefold increase in mortality compared to that of the general population 3 . Fibrotic changes can occur in the glomerulusreferred to as glomerulosclerosis -or in the tubules -referred to as tubulointerstitial fibrosis 4, 5 . Of note, glomerulosclerosis and tubulointerstitial fibrosis involve similar cellular changes, involving the loss of epithelial cells and their vascular capillary bed and the accumulation of activated myofibroblasts, matrix, and inflammatory cells 6 . Matrix build-up, which results from fibroblast transdifferentiation and proliferation, is the sine qua non of fibrosis. Myofibroblast activation is a reactive process that develops in response to epithelial injury, paracrine signalling and cytokine production 7 . In the tubulointerstitium, activated myofibroblasts mostly originate from resident fibroblasts or pericytes 8, 9 . In the glomerulus, mesangial cells take on myofibroblast-like characteristics, including matrix secretion, proliferation and transdifferentiation 4 . Although myofibroblast activation results in the critical histological characteristics of fibrosis, the functional decline in the kidney is caused by a loss of differentiated epithelial cells.
Genome-wide transcriptome analysis of kidneys from patients with CKD and fibrosis showed that genes belonging to the Notch, Wnt and Hh signalling pathways are differentially expressed between patients with renal fibrosis and healthy control individuals 10 . These three pathways act through different signalling mechanisms, but all have a critical role in kidney development. This Review discusses how these three pathways are reactivated in response to renal injury and describes their involvement in the development of renal fibrosis.
Mechanisms of renal fibrosis Epithelial damage and inflammation
Animal model studies indicate that uncontrolled epithelial damage and inflammation are the primary processes that cause fibrosis in the kidney. Several factors can induce excessive epithelial cell injury, including high levels of glucose, free fatty acids, advanced glycation end products, transforming growth factor β, and physical stretch or oncosis 11−15 . In addition to these cell death pathways, detachment also contributes to epithelial cell loss 16 . A decrease in nutrient availability caused by capillary loss often exacerbates epithelial damage 5, 17 . The direct role of epithelial cell loss in fibrosis development is best demonstrated in the glomerulus 18 , as podocytes cannot proliferate or be replaced readily 19 . When podocyte loss exceeds 20%, changes become irreversible causing the entire glomerulus to scar even if the original injury is no longer present 20, 21 . The death of epithelial cells triggers a complex cellular and molecular response. The remaining epithelial cells grow in size and number to cover any exposed basement membrane [22] [23] [24] [25] . Levels of paracrine factors, such as VEGF, secreted by epithelial cells will decrease causing further endo thelial damage and ultimately leading to capillary loss 6, 26, 27 . Epithelial cell injury also triggers the influx of inflammatory cells. These immune cells have an essential role in clearing dead cell remnants and regenerating damaged tubule epithelial cells, and can under some circumstances lead to repair and resolution of injury 28 (FIG. 1) .
Paradoxically, the inflammatory response associ ated with CKD exacerbates epithelial injury and contributes to fibrosis development [29] [30] [31] . Histological analysis of tissue from humans and animal models has shown that the degree of inflammatory cell infiltration strongly correlates with the severity of kidney fibrosis 32 . The increased cytokine production that accompanies fibrosis is mostly controlled by the activity of the transcription factors NF-κB and STAT. Pharmacological inhibition of NF-κB signalling by pyrrolidine dithiocarbamate diminished kidney injury and ameliorated tubular degeneration, tubular necrosis and tubulointerstitial inflammation in mouse models of kidney fibrosis induced by folate or adenine overload 33, 34 . Similarly, genetic deletion of STAT has been shown to ameliorate kidney fibrosis in mice 29, 30, 35 . These studies support the key role of NF-κB, STAT and inflammation in the development of fibrosis.
Although inflammation mostly occurs secondary to epithelial damage, uncontrolled inflammatory reactions, such as those seen in the context of viral or bacterial infections, in transplant recipients and in patients with autoimmune disease, can also be the primary cause of fibrosis 36 . Under these conditions epithelial damage occurs secondary to the inflammatory reaction. Further studies are needed to dissect the role and mechanism of the inflammatory response in fibrosis and to understand the inflammatory processes that result in repair and those that contribute to fibrosis 17 .
Fibroblast activation is a reactive process
The scarring that is characteristic of fibrosis develops because of an increase in the number of activated myofibroblasts, which lay down an excessive amount of extracellular matrix (ECM) 5 . Activated myofibroblasts are usually identified by the expression of α smooth muscle actin (αSMA) and vimentin but also usually express desmin and secrete collagen. The activation and proliferation of myofibroblasts are reactive processes. The number of myofibroblasts in human kidney tissue samples can predict future functional decline in patients with CKD 37 and correlates strongly with epithelial injury. The association between myofibroblast number and epithelial injury in animal models is so strong that epithelial cells have been proposed to directly transdifferentiate into myofibroblasts 38 . Lineage tagging experiments performed in mice using Six2 as a marker of tubule epithelial cells and FoxD1 as a marker of resident fibroblasts indicated that most activated myofibroblasts in fibrotic kidneys originated from resident fibroblasts, as they were the progeny of FoxD1 + cells 9, 39 . In fibrosis, fibroblasts change their characteristics, expressing different ECM proteins and synthesizing greater amounts of collagens, and proteoglycans (fibronectin, laminin and tenascin) 39, 40 . The new ECM composition, in turn, causes alterations in the existing epithelial cells and fibroblasts 40, 41 (FIG. 1) . The excessive amount of fibrillary collagen increases the stiffness of the organ, which causes further myofibroblast activation and epithelial damage 42 . Increased stiffness and matrix is likely needed to make up for the lost epithelial cells. For example in wound healing, myofibroblasts can pull the wound edges together and the increased matrix can reduce the active energy that is needed to keep these sides together 42 . Paracrine factors released by epithelial cells including Tgf-β, Ctgf, Fgf, Pdgf, Il-1, Tnf, angio tensin II and aldosterone, cause fibroblast activation 2, 6, [43] [44] [45] [46] . Tgf-β is thought to be the master regulator of myofibroblast activation and believed to be the key culprit in fibrosis. In rodent models of fibrosis, inhibition of Tgf-β signalling decreased the extent of ECM production 47 . However, Tgf-β also interferes with immune cells, and mice lacking Tgf-β are at increased risk of developing autoimmune disorders 48, 49 . Given that fibroblast activation is a reactive process that occurs in response to epithelial injury, it might seem more appropriate to target the molecular alterations that occur in damaged epithelial cells rather than the fibroblasts themselves.
Notch in kidney development and homeostasis
The Notch signalling pathway is a phylogenetically conserved cell-cell communication mechanism that has multiple functions including roles in cell fate 51 . These receptors are presented on the plasma membrane of the 'signal receiving' cell after undergoing fringe-dependent glycosylation, cleavage by a furin-like convertase (S1 cleavage) and a second cleavage by the ADAM protease receptors (S2 cleavage). The Notch ligands Jagged1 (Jag1), Jagged2 (Jag2), Delta-like 1 (Dll1), Delta-like 3 (Dll3) or Delta-like 4 (Dll4) are expressed on the surface of the 'signal-sending' cells. Binding of the ligand to the receptor initiates a second cleavage by the ADAM protease and a third cleavage of the receptor (S3), after which the intracellular domain of the Notch receptor is transported to the nucleus to act as a transcriptional regulator. The γ-secretase complex mediates this third cleavage step. In the nucleus, the Notch intracellular domain binds to different transcriptional regulators, such as Rbpj and MAML, to regulate expression of target genes, most of which belong to the hairy and enhancer of split (Hes1-7) and hes-related family bHLH transcription factor with YRPW motif (Hey1, Hey2 and HeyL) families 52 (FIG. 2) .
Notch signalling has a critical role in kidney development 53 . Mutations of the Notch ligand, JAGGED1, and Notch receptor, NOTCH2, in humans cause kidney developmental abnormalities 54 . Mouse model experiments showed that Notch2, but not Notch1, is critical for proximal tubular cell fate determination. Few if any proximal tubules and podocytes can be found in mice with a kidney-specific deletion of Notch2 (REF. 55 ).
On the other hand, overexpression of Notch2 directs cells to take on a proximal tubule fate 56 . Genetic deletion of other Notch receptors (Notch3 and Notch4) and ligands (Jagged2 and Delta4) in mice did not induce observable renal defects 53, 57 . As expected, the expression of Notch pathway proteins is largely suppressed once organ development is complete 58 . In most adult organs active Notch signalling is confined to the resident stem cell population. Here, Notch has an important role in maintaining self-renewal, enhancing proliferation and inhibiting differentiation. In addition, as Notch is important in asymmetric cell division, Notch activity is associated with the commitment of cells to specific lineages, for example of Goblet cells in the intestine 59 and of the proximal tubule cells in the kidney 55 . Studies over the past decade have identified cells with progenitor like properties in the adult mouse and human kidney 60, 61 . Cells expressing high levels of Sox9 show progenitor-cell-like characteristics including proliferation and differentiation capacity [62] [63] [64] . Renin-positive, CD133 + or slowly cycling medullary cells have also been shown to have progenitor properties 65, 66 . Although the relationship between Sox9 and renin-expressing progenitor cells is unclear, they both have higher Notch expression than differentiated tubule epithelial cells 60, 64 . The renewal of human tubule epithelial cells is slow in healthy human kidneys, but is greatly accelerated following acute kidney injury (AKI), whereby resident cells proliferate and progenitor cells give rise to new daughter cells. For example, in response to tubule epithelial cell injury, Sox9
+ cells proliferate and differentiate into different tubule segments 64 . Increasing Notch expression in Sox9 + cells accelerated epithelial repair in a mouse model of folic-acid-induced kidney injury 64 . Consistent with this finding, inhibition of Notch with a γ-secretase inhibitor (GSI) delayed recovery in a mouse model of AKI 67 , suggesting that Notch might be involved in cell proliferation and the production of new daughter cells following injury. In contrast to the above findings, however, GSI-mediated inhibition of Notch has also been shown to be protective in AKI models 68, 69 , and genetic overexpression of Notch has been shown to aggravate injury 69 . The reasons for these contradictory results are not clear but it is possible that Notch exerts compartment or temporal-specific roles in AKI and epithelial regeneration (TABLE 1) , with differential effects on proliferation, regeneration and repair depending on the timing and location of Notch activation.
Notch in chronic kidney disease
Both transcript and protein levels of members of the Notch signalling pathway are strongly increased in the glomeruli and tubuli of patients with different forms of CKD, including diabetic nephropathy, lupus nephritis and focal segmental glomerulosclerosis (FSGS) 70 (TABLE 1) .
Notch1 expression in renal tubules correlated with tubulointerstitial fibrosis and decreased kidney function in patients with CKD 70 . Increased Notch receptor, ligand and target gene expression was also reported in mouse models of fibrosis 71 . The functional role of Notch signalling in CKD has been examined using mouse models 71 . Conditional inducible cell-specific expression of cleaved Notch1 in tubule epithelial cells resulted in increased epithelial cell proliferation and tubule epithelial dedifferentiation. The renal histology was characterized by tubule dilatation and atrophy, with accumulation of matrix, myofibroblasts and inflammatory cells in the interstitium 71 . Notch signalling was both sufficient and necessary to induce fibrosis. In mice, genetic deletion of Rbpj, the central transcriptional mediator of Notch signalling in proximal tubular epithelial cells, significantly reduced folic-acid-induced tubulointerstitial fibrosis 71 . Pharmacological inhibition of Notch signalling by injection of a GSI diminished the extent of fibrosis in mouse models of folic acid and unilateral ureteral obstruction (UUO)-induced kidney disease 71 . Treatment with the GSI significantly reduced transcript levels of the fibrosis markers collagen, fibronectin and vimentin, and decreased the expression of the myofibroblast protein αSMA 71 . Although this study strongly supports a role for Notch signalling in the development of fibrosis, it did not establish the ligand and receptor that are responsible for fibrosis development.
A more recent study from 2012 revealed that Notch3 is probably the critical isoform involved in kidney fibrosis 57 . Genetic deletion of Notch3 protected mice from tubulointerstitial fibrosis induced by UUO. In Notch3-knockout mice, the number of αSMA + cells was significantly decreased, indicative of reduced myofibroblast activation 57 . Immunostaining analysis and cell culture studies indicated that Notch3 is expressed in tubule epithelial cells 57 . As this study used global Notch3-knockout mice it was not able to define the cell types in which Notch3 has a role. Global Notch1 and Notch2 knockouts are lethal, so segment-specific deletions will be necessary to investigate the effects of these receptors.
The mechanism by which Notch signalling contributes to the development of fibrosis is not fully understood. Expression of Notch receptors in tubular epithelial cells in vitro can drive transdifferentiation of epithelial cells into activated myofibroblasts (epithelial-to-mesenchymal transition (EMT)) 71 . Notch is a strong regulator of the master transcription factors of EMT: Snai1 and Snai2 (REFS 72, 73) . Snai1 expression in tubule epithelial cells has a key role in the development of kidney fibrosis 74, 75 . As mentioned earlier, linage-tracing studies do not support the role of EMT in kidney fibrosis development; however, some studies 74, 75 suggest that epithelial cells undergo partial EMT, which seems to be an analogous process to that of dedifferentiation. Notch is important in this process as gene expression studies performed in transgenic animals with tubule-specific expression of Notch indicate that Notch promotes the proliferation of epithelial cells and inhibits the expression of tubule epithelial differentiation markers, such as certain solute carriers 71 . This role is very similar to the role of Notch in the stem cell niche 76 and is likely to be important in replacing lost epithelial cells following injury 53, 77, 78 . The re-expression of Notch in the context of kidney injury and fibrosis is therefore not surprising as regeneration uses pathways similar to those that are active during development in other systems such as in skin 79 . Although this wave of proliferation of undifferentiated cells is likely critical for replacing lost tubule cells, the block that Notch places on differentiation on the other hand probably impedes the function of the organ.
Another important issue to consider is how epithelial Notch signalling is transmitted to fibroblasts to induce their proliferation and transdifferentiation. As an important cell-cell communication pathway, Notch signalling alone could be directly responsible for transmitting these signals or these signals could be transmitted via other paracrine signalling pathways. Increased epithelial expression of Notch was associated with increased levels of Tgf-β, which suggests that Tgf-β could be a soluble mediator that stimulates myofibroblast activation following epithelial injury 71, 80 . As discussed in further detail below, the potential interaction of Notch with Wnt and Hh signalling might also have a role in the development of fibrosis 47, 81, 82 .
Notch signalling and podocytes
In addition to their increased expression in tubular epithelial cells, increased expression of Notch proteins has also been observed in glomerular epithelial cells of patients with CKD, including those with diabetic kidney disease and FSGS 83 . The expression of cleaved Notch1 in podocytes and glomeruli correlated with albuminuria and glomerulosclerosis, whereas glomerular expression of Jagged1 and activated Notch2 was associated with proteinuria alone 70 . Notch expression was also increased in podocytes of mouse models of diabetic kidney disease 83 . Mechanistic studies showed that conditional inducible expression of the intracellular domain of Notch1 in murine podocytes resulted in albuminuria, glomerulosclerosis, tubulointerstitial fibrosis and death of the animals 83 . The histological lesions in these animals resembled FSGS. The timing of Notch expression had a slight effect on the histological FSGS subtype: early (developmental) expression induced collapsing FSGSlike lesions whereas expression on adult cells resulted in classic FSGS lesions 84 . Notch seems to not only be sufficient to induce sclerosis of the glomerulus, but also necessary, as genetic deletion of Rbpj from podocytes reduced albuminuria in diabetic mouse models 83 . On a mechanistic level, Notch functions to inhibit podocyte differentiation 83, 85 , similar to its role in tubule cells. Notch expression in developing podocytes also induces proliferation; however, mature podocytes cannot proliferate and Notch expression causes a mitotic catastrophe resulting in podocyte death 83 . Notch1 and Notch2 might have different roles in podocytes. A 2014 study reported a positive linear correlation between the number of podocytes expressing activated Notch2 and the number of residual podocytes in human nephrotic syndrome specimens 86 . This study also showed that administration of a Notch2 agonistic monoclonal antibody ameliorated proteinuria and glomerulosclerosis in a mouse model of nephrosis and FSGS. In vitro, knockdown of Notch2 increased apoptosis of damaged podocytes, while Notch2 agonistic antibodies enhanced activation of Akt and protected damaged podocytes from apoptosis 86 . Our group has performed genetic studies to specifically study the role of Notch1 and Notch2 in podocytes 87 . We found that genetic deletion of Notch1 in podocytes resulted in marked amelioration of diabetic kidney disease. By contrast, podocytespecific genetic deletion of Notch2 had no effect on albuminuria and mesangial expansion. Notch1-null podocytes were protected from apoptosis and dedifferentiation in vitro, likely explaining the protective phenotype in vivo. Deletion of Notch1 in podocytes also resulted in an increase in Notch2 expression, indicating inter action between the receptors. At the same time, transgenic overexpression of Notch2 in podocytes did not induce phenotypic changes 87 . These results indicate that Notch1 has a dominant damaging role in the glomerulus.
More recently, Notch3 was proposed to be a player in the development of glomerular disease 88 . Increased Notch3 expression was described in glomerular podocytes of patients with lupus nephritis or FSGS, as well as in animal models of rapidly progressive glomerulonephritis. Mice lacking Notch3 were protected as they exhibited less proteinuria and structural damage than did wild-type mice. In vitro studies showed that podocytes expressing active Notch3 reorganize their cytoskeleton toward a proliferative/migratory and inflammatory phenotype. Antisense oligodeoxynucleotides targeting Notch3 ameliorated kidney injury and inflammatory infiltration of the kidney, associated with fewer fibrin deposits in glomeruli and decreased peritubular inflammation 88 . These studies indicate that Notch1, Notch2 and Notch3 not only have differential roles during development, but also exert differential effects in the adult human kidney depending on the injury model studied.
Wnt in kidney development and homeostasis Wnt signalling was first recognized for its important role in carcinogenesis, but this pathway is now known to have key roles in embryonic development 89, 90 and in the stem cell compartment [91] [92] [93] . To date, 19 Wnt ligands and 15 receptors and co-receptors have been identified, making it difficult to elucidate the complex molecular processes involved in and regulated by Wnt signalling 91 . Wnt proteins are a group of secreted lipid-modified glycoproteins, many of which act through the canonical Wnt pathway in which β-catenin is a key mediator. In the steady state, the so-called 'destruction complex' , which consists of glycogen synthase kinase 3β (GSK3β), the scaffolding Myofibroblast differentiation Repair protein axin, casein kinase 1α, and the adenomatous polyposis coli protein, phosphory lates cytoplasmic β-catenin at the N-terminal residue, which leads to its ubiquitinmediated proteasomal degradation. However, when Wnt proteins are present they bind to Frizzled (Fzd) and LRP5/6 receptor proteins, promoting the inactivation of GSK3β and disassembly of the destruction complex. Non-phosphorylated β-catenin accumulates in the cytoplasm and translocates into the nucleus, where it binds to T-cell factor (TCF) and lymphoid enhancer factor (LEF) to regulate Wnt target genes 91, 93 (FIG. 3) . Wnt molecules can also signal independently of LRP5/6 and β-catenin in a so-called 'non-canonical' manner, mostly acting via the planar cell polarity pathway 94, 95 . Wnt4 and Wnt9b are important in kidney development. During development, Wnt proteins stimulate uncommitted mesenchymal cells to differentiate into epithelial cells (mesenchymal-to-epithelial transition
[MET]) 96 . In addition, reciprocal Wnt signals between kidney stromal cells and renal epithelial cells are critical in regulating nephron elongation and differentiation 97, 98 . Using reporter mouse cell lines, a high-level of Wnt activity has been observed in the renal medulla in adult mouse kidneys. Findings from a 2004 study indicated that these medullary cells might act as stem or progenitor cells in the kidney 99 . A later report confirmed that Wnt-responsive cells are likely to be progenitor or stem cells. Scattered Wnt-responsive cells were reported to act as progenitor or stem cells, and to contribute to kidney regeneration after injury 100 . A concerted upregulation of multiple Wnt ligands (Wnt2, Wnt2b, Wnt4, Wnt5a, Wnt7b and Wnt10b) has been described in mouse models of acute ischaemiareperfusion injury 98, 101, 102 (TABLE 2) . Since Wnt proteins are located in the stem cell compartment, their increased expression in response to epithelial injury is In the absence of Wnt ligands, cytoplasmic β-catenin is phosphorylated by the 'destruction complex', which contains glycogen synthase kinase 3β (GSK3β), the scaffolding protein axin, casein kinase 1a (CK1a), and the adenomatous polyposis coli protein (APC), and then undergoes ubiquitin-mediated proteasomal degradation. In fibrotic kidneys, binding of Wnt to Frizzled (Fzd) and LRP5/6 receptor proteins inactivates GSK3β and disassembles the destruction complex. Accumulation of non-phosphorylated β-catenin in the cytoplasm leads to its translocation into the nucleus (canonical Wnt signalling). In the nucleus, β-catenin replaces Groucho from TCF and LEF and activates Wnt target gene expression. Increased tubule-specific expression of β-catenin has been described in chronic kidney disease. Myofibroblasts can express Wnt4, which induces proliferation of resident fibroblasts and their transformation into myofibroblasts. Wnt/β-catenin signalling in pericytes and interstitial fibroblasts induces spontaneous myofibroblast differentiation, an important step in fibrosis development. Macrophage expression of Wnt7b is associated with epithelial repair. The β-catenin-independent (non-canonical) Wnt signalling pathway regulates cytoskeleton rearrangement, cell adhesion and cell movement via the kinases Rho, Rac and Cdc42.
not surprising, and is indicative of their role in cell regeneration. Wnt4, in particular, contributes to the regeneration of tubular epithelial cells by regulating the cell-cycle proteins cyclin D1 and cyclin A 98, 103 . Macrophages that accumulate in regenerating kidneys express Wnt ligands, including Wnt4, Wnt7b, Wnt10a and Wnt10b, on their surface 98, 101 . High Wnt ligand expression in isolated macrophages and an increased Wnt signalling response in epithelial cells have been observed following ischaemia-reperfusion injury in mice 101 . Ablation of macrophages in vivo in mice led to reduced expression of Wnt, indicating that Wnt is derived from this compartment. Macrophage-specific deletion of Wnt7b resulted in impaired epithelial cell regeneration and increased epithelial injury 101 . This study thereby demonstrates that the influx of macrophages has a critical role in orchestrating the repair of epithelial cells by secreting Wnt7b. Consistent with these studies genetic deletion of β-catenin from renal tubule epithelial cells exacerbates AKI 104 . The effects of Wnt inhibitors in the context of kidney injury are summarized in β-catenin are not only regulated in CKD, but also contribute to fibrosis development. Genetic overexpression of active β-catenin in tubular cells induces some features of fibrosis, including epithelial dedifferentiation and EMT in mice 104, 106 . In line with this finding, a reduction in Wnt/β-catenin activation is associated with significantly improved outcomes in renal fibrosis models. The outcomes of several strategies that interfere with Wnt signalling at different levels have been published (TABLE 3) . Dickkopf1 (Dkk1) is a Wnt antagonist that binds to the LRP5/6 receptor and inhibits the canonical Wnt pathway. Injection of a vector encoding Dkk1 into mouse models of kidney fibrosis reduced β-catenin accumulation and fibrosis, as evidenced by reduced collagen deposition, decreased interstitial expansion and reduced levels of the αSMA protein 105 . Secreted frizzled-related protein 1 (Sfrp1) acts as a biphasic modulator of Wnt signalling, counteracting Wnt-induced effects at high concentrations and promoting them at lower concentrations 107 . Mice lacking Sfrp1 had an increased level of fibrosis with increased vimentin and αSMA expression levels following UUO injury 108 . Deletion of Dapper3, another Wnt antagonist, resulted in accumulation of dishevelled 2 and β-catenin, activation of Wnt-targeted profibrotic genes and an exacerbated fibrotic phenotype in the UUO model 109 .
Small molecules that interfere with Wnt signalling also modulate the development of fibrosis and could represent a new therapeutic avenue 110 . The vitamin D analogue paricalcitol has been proposed to inhibit Wnt/β-catenin signalling by competing with TCF-4 for β-catenin (TABLE 3) and thereby protects against the development of fibrosis 98, 111 . The small molecule Wnt/ß-catenin inhibitor ICG-001 also reduced fibrosis development 112 . Although these studies indicate that Wnt is an essential modulator of fibrosis development, the conditional, tubule-specific deletion of β-catenin in mice had no effect on renal fibrosis development in a UUO-induced injury model 106 . These findings potentially indicate that tubular cells might not be the target of Wnt signalling in fibrosis. In support of this notion, lineage-tracing studies revealed that Wnt4 expression was high in activated myofibroblasts, especially in the medullary interstitium following UUO or ischaemia-reperfusion injury in mice 113 . In vitro, in mouse kidney cells administration of exogenous Wnt4 drove myofibroblast differentiation, but conditional deletion of Wnt4 in interstitial cells did not reduce myofibroblast proliferation, cell numbers, or expression of myofibroblast-specific genes during fibrosis (TABLE 2) . A mouse model with constitutive activation of canonical Wnt4/β-catenin signalling in interstitial pericytes and fibroblasts exhibited spontaneous αSMA, α smooth muscle actin; Dkk, Dickkopf; Fzd, Frizzled; IRI, ischaemia-reperfusion injury; LRP, low-density lipoprotein receptor-related protein; Sfrp, secreted frizzled-related protein; TCF-4, T-cell factor-4; Tgf-β, tumour growth factor-β; UUO, unilateral ureteral obstruction.
myofibroblast differentiation even in the absence of injury 113 . These results indicate that Wnt4/β-catenin in fibroblasts is sufficient, but Wnt4 is not required, for fibrosis development, and potentially suggest that Wnt signalling could be a communication mechanism between injured tubular epithelial cells and fibroblasts. Lastly we should note that the effect of Wnts could also be independent of β-catenin, mediated through the non-canonical Wnt signalling pathway. For example Wnt11, an important profibrotic mediator of Tgf-β that drives the expression of mesenchymal genes, exerts its action independent of β-catenin 114 .
Wnt signalling and podocytes
Increased Wnt activity has been observed in glomeruli of mouse models of CKD 115, 116 . Wnt expression was increased in podocytes of mice treated with adriamycin, a substance that induces podocyte injury with features similar to that of FSGS. Hydrodynamic-based tail vein injection of exogenous Wnt1 into BALB/c mice exacerbated podocyte dysfunction, which was evidenced by decreased protein levels of nephrin. Blocking Wnt signalling with DKK1 in adriamycin-injected mice ameliorated albuminuria and counteracted the decrease in nephrin levels 116 . Furthermore, podocyte-specific deletion of β-catenin protected mice from adriamycin-induced podocyte injury, including albuminuria and podocyte foot process effacement 116 . ICG-001 was similarly effective in ameliorating proteinuria in the adriamycin-induced glomerular injury model. The authors propose that the effect of Wnt on proteinuria is mediated by regulating the expression of the renin-angiotensin system, as they described binding of β-catenin to the promoter of renin and the angiotensin receptors 112 . The effect of Wnt signalling seems to be context dependent. Studies from our laboratory showed that genetic deletion of β-catenin from podocytes did not protect mice from developing diabetic nephropathy 115 . Indeed, we found that mice with podocyte-specific deletion of β-catenin had increased albuminuria and glomerulosclerosis. Genetic overexpression of β-catenin in podocytes resulted in low-grade albuminuria and minor alterations in the basement membrane. In vitro experiments in mouse podocytes showed that increased Wnt/β-catenin activation in podocytes induced loss of expression of markers associated with differentiated podocytes. Decreased Wnt/β-catenin signalling was necessary for full differentiation of podocytes, but these 'highly' differentiated cells showed an increased susceptibility to apoptosis 115 .
Hedgehog in kidney development
The Hedgehog (Hh) pathway has a fundamental role in tissue patterning, cell growth and differentiation 117, 118 . In adult tissues, Hh signalling is important for maintenance of the stem cell compartment 119, 120 . Aberrant Hh signalling has been reported in many cancer types, including basal cell, prostate, mammary gland, and lung 121, 122 . The three Hh ligands, Sonic hedgehog (Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh), are lipid-modified proteins that can act over short and long distances from their source of secretion. In humans, Hh molecules initiate signalling by binding to their receptor Patched1 (PTCH1), which results in ciliary localization of the G-protein coupled receptor-like protein Smoothened (SMO). SMO mediates the translocation of full-length GLI proteins to the nucleus, therein activating expression of Hh target genes, including GLI1, PTCH1, CCND1, MYC, JAG2, BCL2 and SNAI1 (REFS 117, 121) . In the absence of Hh proteins, the ciliary localization of SMO is inhibited, which leads to sequestration of GLI proteins. Following proteolytic cleavage, the C-terminal-shortened GLI repressor binds to DNA, inhibiting target gene transcription 117, 119 (FIG. 4) .
Three GLI transcription factors are important in mediating Hh signalling. GLI2 and GLI3 are thought to have activator and repressor functions, whereas GLI1 only acts as an activator 123 . In patients with PallisterHall syndrome, frameshift mutations have been described in the GLI3 gene, which produce an abbreviated protein with similarities to the GLI3 repressor. Hydronephrosis, renal hypoplasia and renal dysplasia characterize the associated autosomal dominant disorder 117 . Genetic deletion of GLIS2 (GLI-similar 2) is associated with nephronophthisis and interstitial fibrosis in humans 124 . By binding cis-acting regulatory sequences in the 5ʹ flanking regions of Snai1 and Wnt4, Glis2 seems to inhibit Gli1 activity leading to maintenance of tubular differentiation 125 . Although these genetic studies indicate that Hh signalling has key role in kidney development, its role in kidney homeostasis or its potential role in maintaining the resident stem cell niche has not been studied.
Hedgehog signalling in renal fibrosis
The functional role of Hh in healthy and diseased kidneys is just beginning to be understood. Detection of Hh and its associated genes in healthy human and mouse kidneys is difficult due to their low level of expression. Linage tracing indicates that Shh expression is localized to aquaporin 2-positive collecting ducts 126 . Proximal tubule cells, on the other hand, seem to express Ihh. The Hh receptor Ptch1 and effector gene Gli are expressed by interstitial cells 126 . One group reported increased Shh expression in injured tubule epithelial cells in mouse models of UUO and ischaemia-reperfusion injury-induced kidney fibrosis 127 . However, another study did not confirm the increased Shh expression in the UUO mouse model system 126 . On the other hand, there was a consensus by both studies that Gli expression is increased in interstitial fibroblasts in various mouse fibrosis models 126, 127 . Mechanistic studies indicate that the Hh pathway has an important functional role in fibrosis development in the kidney and in the heart. In vitro studies suggest that Hh promotes myofibroblastic transdifferentiation and proliferation of interstitial fibroblasts. Rat kidney fibroblasts treated with Shh in vitro showed increased expression of αSMA and cell-cycle-associated gene expression 128 . On the other hand Shh treatment did not alter the phenotype of cultured tubule epithelial cells 127 . Inhibition of Hh signalling by cyclopamine, a potent inhibitor of SMO, significantly attenuated kidney fibrosis development in mouse models of ischaemia-reperfusion injury and obstructive nephropathy 127, 128 . The source of Shh seems to be tubule epithelial cells as expression of Shh on tubule cells in vivo was sufficient to induce myofibroblast proliferation and fibrosis development 127 . Studies over the past couple of years have defined a critical role for Gli and Gli-expressing fibroblasts in mediating the fibrotic response to Hh signalling [128] [129] [130] . A subset of myofibroblasts express high levels of Gli1 and exhibit stem cell characteristics in vitro and in vivo.
Genetic ablation of Gli1
+ cells reduced kidney damage in mouse models of kidney fibrosis 128 . Gli + cells also seem to mediate fibrosis in other organs; in the heart, for example, genetic ablation of Gli1 + cells, even in the setting of actively established cardiac fibrosis, resulted in reversal of cardiac fibrosis and improved heart function 130 . These studies suggest that the Hh signalling pathway has a key role in the development of renal fibrosis, mostly through secretion of Hh ligands from epithelial cells and Gli1 upregulation in myofibroblasts.
Interaction of developmental pathways Notch and Wnt signalling strongly interact with each other in both synergistic and antagonistic manners depending on the microenvironment. Crosstalk between Notch and Wnt signalling has initially been described in the development and patterning of the Drosophila wing 82 . The two signalling pathways primarily synergize to regulate growth of the early wing tissue; later in development, Notch signalling promotes wingless (the Drosophila Wnt orthologue) expression at the wing margin. Conversely, wingless regulates expression of the Notch ligands Serrate (the Drosophila Jagged orthologue) and Delta to coordinate the detailed patterning of the wing. Notch has also been found to downregulate wingless by establishing a complex with β-catenin and promoting β-catenin degradation in Drosophila
82
. During kidney development, the sequential activation of Wnt signalling is necessary to build up a mesenchymal stem cell pool originating from epithelial cells through the process of MET. Wnt9b-induced cells exit the stem cell niche and become epithelial cells mostly by expressing Wnt4. In the absence of Notch or Wnt signalling, MET is absent and nephrons do not develop, resulting in kidney failure and death of newborn mice. Notch2 activation follows Wnt activation and is needed for determination of proximal-distal tubular cell fate 96 . Notch activation can bypass the need for Wnt activation in the developing mouse kidneys, whereas overexpression of Wnt3a can bypass the need for Notch signalling, as shown in chick kidney developmental models 131 . A positive feedback loop between Notch2 and Wnt4 also exists, with Notch2 promoting proximal tubule fate by inducing cell differentiation and thereby depleting the progenitor cell population 56 . The Notch and Wnt pathways also interact in tissueresident stem cells. In the intestine, for example, high Wnt activity has been observed in the Lgr5 + stem cell population 132 . This high Wnt activity is necessary for maintaining the stemness of this population 133 . Notch and Wnt signalling interact to regulate transit amplification and lineage determination of the intestinal cells 76, 134 . A similar mechanism is likely to be present in the kidney as Wnt-responsive, Lgr5
+ and Sox9 + cells showed stem or progenitor cell characteristics and transcriptome profiling studies revealed high Jagged1 expression in these cells 60 . These studies indicate that Wnt and Notch interact mostly synergistically in the stem cell and epithelial cell compartment 81, 135 . Their effect seems to be similar; , which leads to localization of SMO to the primary cilium. Ciliary SMO mediates the translocation of full-length active GLI to the nucleus, where it binds to DNA and activates expression of Hh target genes. In the steady state, GLI proteins are sequestered by Kif7/Kif27, Fused (Fu) and the Suppressor of Fused (Sufu) and phosphorylated by protein kinase A (PKA), casein kinase 1 (CK1) and glycogen synthase kinase 3β (GSK3β). This modification allows proteolytical cleavage of GLI by β-transducin repeat containing protein (βTrCP). The now C-terminal shortened GLI repressor binds to the DNA inhibiting Hh target gene transcription. In fibrotic kidneys, Gli1-expressing pericytes have an important role in interstitial fibrosis, undergoing myofibroblast transformation and proliferation.
they are activated following injury to enhance proliferation and inhibit differentiation. They most likely contribute to fibrosis development by inhibiting epithelial differentiation.
These pathways also interact by promoting the transformation of fibroblasts into activated myofibroblasts in fibrosis. In vitro, Hh treatment results in myofibroblastic transdifferentiation and the proliferation of resident fibroblasts 127, 128 . Transgenic expression of Wnt4 similarly resulted in myofibroblastic transdifferentiation and proliferation 113 , indicating that the phenotypic outcome of Wnt and Hh overlaps, and raising the possibility of synergy. Although Notch expression has not been studied in renal fibroblasts, studies indicate that interstitial expression of Notch contributes to fibrosis development in the lung 136 . TGF-β might also be involved in mediating the effects of these signalling pathways on renal fibrosis. Thus, although Notch, Wnt and Hh are critical morphogens with important roles in kidney development, it seems that their choreographed expression is also critical for organ fibrosis.
Conclusions
Overall, we can observe similar patterns of activity among the Notch, Wnt and Hh pathways. In adult organs, the expression of the components of these pathways is fairly low and in most organs their expression is restricted to the stem/progenitor cell compartment. Early results indicate a similar expression pattern and functional role in the kidney, but further studies are needed to explore this possibility.
Following injury, the expression of Notch, Wnt and Hh ligands and receptors has been shown to increase in mouse and in human kidney tissue samples 70, 98, 128 . Increased Wnt signalling in the progenitor or stem cell niche seems to initiate a proliferative response in stem cells 137 . Notch and Wnt signalling can maintain the proliferation wave in the transit-amplifying population. These pathways likely interact in this niche and Hh might also be important in the process. In acute injury, transient activation of Wnt is likely to contribute to the regeneration of tubule epithelial cells; the role of transient Notch activation in tubule regeneration is less clear 47 . Sustained injury in CKD results in sustained activation of the Wnt and Notch pathways in epithelial cells. In addition, cells in which these pathways are active are likely to preferentially expand. Sustained high expression of members of the Wnt and Notch pathways prevents the terminal differentiation of epithelial cells. Therefore, inhibiting Wnt and Notch signalling probably enables terminal differentiation of epithelial cells and could lead to improved histological and functional outcomes.
Future studies should focus on defining the similarities and differences between the various Notch ligands and receptors in health and disease. Indeed, despite their remarkable similarities, different Notch ligands and receptors have a non-overlapping role in kidney development, and consequently, they probably also have different roles in kidney disease 70 . As Wnt, Notch and Hh are paracrine signalling pathways, it will be important to determine the direction of signalling and their precise role in mediating epithelial, fibroblastic, endothelial and immune cell inter actions. For example, the Hh targets Gli2 and Wnt4 are specifically expressed in myofibroblasts and are responsible for myofibroblastic transformation and proliferation 113, 129 . A tight balance between the activities of these signalling pathways is essential to maintain homeo stasis. Although these pathways are necessary for organ maintenance, it seems that the development of fibrosis might be the inevitable downside of a cell-survival response.
